RESÚMENES MAYO 2009

.

Mood - Anxiety Disorders & Antidepressants – Mood Stabilizers

 (Haga un click en la información del journal para acceder al resúmen)

5 – doble-ciego o metanálisis; 4 – subanálisis o simple ciego; 3 – revisión, abierto, básico; 2 – casos; 1 – opinión

GRATIS = Texto gratuito en algunos países de la región iberoamericana (algunos artículos requieren ir a la tabla de contenidos del número actual de la revista)

 

3 - Lithium levels in drinking water and risk of suicide

Hirochika Ohgami, Takeshi Terao, Ippei Shiotsuki, and Nobuyoshi Ishii, Noboru Iwata

The British Journal of Psychiatry (2009) 194: 464-465

 

3 - Clinical outcome and tolerability of duloxetine in the treatment of major depressive disorder: a 12-week study with plasma levels

LS Volonteri, A Colasanti, G Cerveri, A Fiorentini, IF De Gaspari, MC Mauri, A Valli, P Papa, and C Mencacci

Journal of Psychopharmacology First published on April 30, 2009

 

5< - A controlled trial of antidepressants in patients with Parkinson disease and depression

M. Menza, R. D. Dobkin, H. Marin, M. H. Mark, M. Gara, S. Buyske, K. Bienfait, and A. Dicke

NEUROLOGY 2009;72:886-892

3! - Trends in Antidepressant Utilization From 2001 to 2004

Jeffrey S. Harman, Mark J. Edlund, and John C. Fortney

Psychiatr Serv 60:611-616, May 2009

3! - Antidepressant Switching Among Adherent Patients Treated for Depression

Steven C. Marcus, Mariam Hassan, and Mark Olfson

Psychiatr Serv 60:617-623, May 2009

3! - Major Depression and Antidepressant Treatment: Impact on Pregnancy and Neonatal Outcomes

Katherine L. Wisner, Dorothy K.Y. Sit, Barbara H. Hanusa, Eydie L. Moses-Kolko, Debra L. Bogen, Diane F. Hunker, James M. Perel, Sonya Jones-Ivy, Lisa M. Bodnar, and Lynn T. Singer

Am J Psychiatry 2009; 166:557-566

3! - Long-Term Use of Antidepressants for Depressive Disorders and the Risk of Diabetes Mellitus

Frank Andersohn, René Schade, Samy Suissa, and Edeltraut Garbe

Am J Psychiatry 2009; 166:591-598

3! - Can Phase III Trial Results of Antidepressant Medications Be Generalized to Clinical Practice? A STAR*D Report

Stephen R. Wisniewski, A. John Rush, Andrew A. Nierenberg, Bradley N. Gaynes, Diane Warden, James F. Luther, Patrick J. McGrath, Philip W. Lavori, Michael E. Thase, Maurizio Fava, and Madhukar H. Trivedi

Am J Psychiatry 2009; 166:599-607

3! - The Incidence and Course of Depression in Bereaved Youth 21 Months After the Loss of a Parent to Suicide, Accident, or Sudden Natural Death

David Brent, Nadine Melhem, M. Bertille Donohoe, and Monica Walker

Am J Psychiatry Published May 1, 2009

3 - selective serotonin reuptake and dual serotonergic–noradrenergic reuptake treatments on memory and mental processing speed in patients with major depressive disorder

Ixchel Herrera-Guzmán, Esteve Gudayol-Ferré, Daniel Herrera-Guzmán, Joan Guàrdia-Olmos, Erika Hinojosa-Calvo and Jorge E. Herrera-Abarca

Journal of Psychiatric Research. Volume 43, Issue 9, June 2009, Pages 855-863 3! - Effects of

 

3! - The effect of trimipramine on dream recall and dream emotions in depressive outpatients




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Michael Schredl, Mathias Berger and Dieter Riemann

Psychiatry Research. Volume 167, Issue 3, 30 May 2009, Pages 279-286

 

3! - A Novel Examination of Atypical Major Depressive Disorder Based on Attachment Theory

Robert D. Levitan, Leslie Atkinson, Rebecca Pedersen, Tom Buis, Sidney H. Kennedy, Kevin Chopra, Eman M. Leung, and Zindel V. Segal

J Clin Psychiatry May 5, 2009: e1-e9

 

3 - Psychopharmacological Combination Therapy in Bipolar Disorder

A. Quante, F. van Hall, I. Anghelescu

Fortschr Neurol Psychiatr 2009; 77: 252-262

3! - Volumetric differences in the pituitary between drug-naïve and medicated male patients with obsessive–compulsive disorder




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Myung Hun Jung, Min Jung Huh, Do-Hyung Kang, Jung-Seok Choi, Wi Hoon Jung, Joon Hwan Jang, Ji-Young Park, Ji Yeon Han, Chi-Hoon Choi and Jun Soo Kwon

Progress in Neuro-Psychopharmacology and Biological Psychiatry. Volume 33, Issue 4, 15 June 2009, Pages 605-609

 

3! - Observational study designs for bipolar disorder — What can they tell us about treatment in acute mania?




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Catherine Reed, Diego Novick, Ana Gonzalez-Pinto, Jordan Bertsch and Josep Maria Haro

Progress in Neuro-Psychopharmacology and Biological Psychiatry. Volume 33, Issue 4, 15 June 2009, Pages 715-721

 

3! - Higher plasma interleukin-6 (IL-6) level is associated with SSRI- or SNRI-refractory depression




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Reiji Yoshimura, Hikaru Hori, Atsuko Ikenouchi-Sugita, Wakako Umene-Nakano, Nobuhisa Ueda and Jun Nakamura

Progress in Neuro-Psychopharmacology and Biological Psychiatry. Volume 33, Issue 4, 15 June 2009, Pages 722-726

 

3 - A review of valproate in psychiatric practice

Peter M Haddad, Amlan Das, Muhammad Ashfaq & Angelika Wieck

Expert Opinion on Drug Metabolism & Toxicology. May 2009, Vol. 5, No. 5, Pages 539-551 , DOI

 

3! - Vilazodone: A 5-HT1A Receptor Agonist/Serotonin Transporter Inhibitor for the Treatment of Affective Disorders

Lee A. Dawson & Jeannette M. Watson

CNS Neuroscience & Therapeutics. Volume 15 Issue 2, Pages 107 - 117

 

3! - Influence of gender and menopausal status on antidepressant treatment response in depressed inpatients

M Vermeiden, WW van den Broek, PGH Mulder, and TK Birkenhäger

Journal of Psychopharmacology First published on May 7, 2009

3 - Treatment response and duration of maintenance treatment with adjunctive antidepressants in bipolar depression: A retrospective chart review

Shi Hyun Kang;  Yang-Jin Kim;  Hoyoung An;  Yeon Ho Joo; Chang Yoon Kim

International Journal of Psychiatry in Clinical Practice, Volume 13, Issue 2 June 2009, pages 130 - 137

 

3 - Switching to duloxetine from selective serotonin reuptake inhibitors in non- or partial responders: Results from a Spanish sample

Romera Irene;  Montejo Angel Luis;  Delgado-Cohen Helena;  Perahia David;  Domenech Josep Ramon; Gilaberte Inmaculada

International Journal of Psychiatry in Clinical Practice, Volume 13, Issue 2 June 2009, pages 100 - 108

 

3! - Treating depression with different galenical drug formulations: Does it make a difference? The comparison of mirtazapine fast dissolving formulation (FDT) with conventional mirtazapine tablets (CT)

Alexandra Delini-Stula;  Helga van Oers;  Arjen van Willigenburg;  Bjorn Oddens;  Albert-Jan Schutte; Egbert van der Meulen

International Journal of Psychiatry in Clinical Practice, Volume 13, Issue 2 June 2009, pages 109 - 116

 

3 - Screening for bipolar disorder in medicated patients treated for unipolar depression in a psychiatric outpatient clinic using the Mood Disorder Questionnaire

Yu Ting Wang;  Tzung Lieh Yeh;  I Hui Lee;  Kao Ching Chen;  Po See Chen;  Yen Kuang Yang; Ru Band Lu

International Journal of Psychiatry in Clinical Practice, Volume 13, Issue 2 June 2009, pages 117 - 121

 

GRATIS 3! - Accumulation of major depressive episodes over time in a prospective study indicates that retrospectively assessed lifetime prevalence estimates are too low

Scott B Patten

BMC Psychiatry 2009, 9:19

 

3 - How could MDMA (ecstasy) help anxiety disorders? A neurobiological rationale

PØ Johansen, TS Krebs

Journal of Psychopharmacology, Vol. 23, No. 4, 389-391 (2009)

3 - Behavioural signs of depression and apoptosis in the limbic system following myocardial infarction: effects of sertraline

BP Wann, TM Bah, S Kaloustian, M Boucher, AM Dufort, N Le Marec, R Godbout, G Rousseau

Journal of Psychopharmacology, Vol. 23, No. 4, 451-459 (2009)

3 - Clinical Importance of Sleep Disturbance as a Treatment Target in PTSD

R. Bruce Lydiard, and Mark H. Hamner

Focus 7:176-183, Spring 2009

4 - Decreased Glutamate/Glutamine Levels May Mediate Cytidine's Efficacy in Treating Bipolar Depression: A Longitudinal Proton Magnetic Resonance Spectroscopy Study

Sujung J Yoon, In Kyoon Lyoo, Charlotte Haws, Tae-Suk Kim, Bruce M Cohen and Perry F Renshaw

Neuropsychopharmacology (2009) 34, 1810–1818

 

3 - The Safety, Acceptability, and Effectiveness of Acupuncture as an Adjunctive Treatment for Acute Symptoms in Bipolar Disorder

Ellen B. Dennehy, Rosa Schnyer, Ira H. Bernstein, Robert Gonzalez, Geetha Shivakumar, Dorothy I. Kelly, Diane E. Snow, Suresh Sureddi, and Trisha Suppes

J Clin Psychiatry May 5, 2009: e1-e9

 

3! - A Long-Term Trial of the Effectiveness and Safety of Atypical Antipsychotic Agents in Augmenting SSRI-Refractory Obsessive-Compulsive Disorder

Hisato Matsunaga, Toshihiko Nagata, Kazuhisa Hayashida, Kenzo Ohya, Nobuo Kiriike, and Dan J. Stein

J Clin Psychiatry May 5, 2009: e1-e6

 

3! - Serotonergic drugs and valvular heart disease

Richard B Rothman & Michael H Baumann

Expert Opinion on Drug Safety. May 2009, Vol. 8, No. 3, Pages 317-329

 

3! - Benzodiazepine use in the elderly: an indicator for inappropriately treated geriatric depression?

Eva Assem-Hilger, Susanne Jungwirth, Silvia Weissgram, Walter Kirchmeyr, Peter Fischer, Christian Barnas

International Journal of Geriatric Psychiatry. Volume 24 Issue 6, Pages 563 - 569

 

3! - Co-occurrence of depression and anxiety in elderly subjects aged 90 years and its relationship with functional status, quality of life and mortality

Gerda M. Van der Weele, Jacobijn Gussekloo, Margot W. M. De Waal, Anton J. M. De Craen, Roos C. Van der Mast

International Journal of Geriatric Psychiatry. Volume 24 Issue 6, Pages 595 - 601

 

3! - Retrospective age at onset of bipolar disorder and outcome during two-year follow-up: results from the STEP-BD study

Roy H Perlis, Ellen B Dennehy, David J Miklowitz, Melissa P DelBello, Michael Ostacher, Joseph R Calabrese, Rebecca M Ametrano, Stephen R Wisniewski, Charles L Bowden, Michael E Thase, Andrew A Nierenberg and Gary Sachs

Bipolar Disorders. Volume 11 Issue 4, Pages 391 - 400

 

3! - Clinical predictors of functional outcome of bipolar patients in remission

Adriane R Rosa, Maria Reinares, Carolina Franco, Mercè Comes, Carla Torrent, Jose Sánchez-Moreno, Anabel Martínez-Arán, Manel Salamero, Flávio Kapczinski and Eduard Vieta

Bipolar Disorders. Volume 11 Issue 4, Pages 401 - 409

 

3! - A longitudinal study of hypomania and depression symptoms in pregnancy and the postpartum period

Jessica Heron, Sayeed Haque, Femi Oyebode, Nick Craddock and Ian Jones

Bipolar Disorders. Volume 11 Issue 4, Pages 410 - 417

 

3 - Ultra-brief pulse ECT in bipolar and unipolar depressive disorder: differences in speed of response

Pascal Sienaert, Kristof Vansteelandt, Koen Demyttenaere and Joseph Peuskens

Bipolar Disorders. Volume 11 Issue 4, Pages 418 - 424

 

3! - Association between lithium serum level, mood state, and patient-reported adverse drug reactions during long-term lithium treatment: a naturalistic follow-up study

Ingeborg Wilting, Eibert R Heerdink, Peter-Paul A Mersch, Johannes A den Boer, Antoine C G Egberts and Willem A Nolen

Bipolar Disorders. Volume 11 Issue 4, Pages 434 - 440

 

5 - Effects of Testosterone Replacement in Middle-Aged Men With Dysthymia: A Randomized, Placebo-Controlled Clinical Trial

Seidman, Stuart N; Orr, Guy; Raviv, Gil; Levi, Rachel; Roose, Steven P; Kravitz, Efrat; Amiaz, Revital; Weiser, Mark

Journal of Clinical Psychopharmacology: June 2009 - Volume 29 - Issue 3 - pp 216-221

 

5 - Zolpidem Extended-Release Improves Sleep and Next-Day Symptoms in Comorbid Insomnia and Generalized Anxiety Disorder

Fava, Maurizio; Asnis, Gregory M; Shrivastava, Ram; Lydiard, Bruce; Bastani, Bijan; Sheehan, David; Roth, Thomas

Journal of Clinical Psychopharmacology: June 2009 - Volume 29 - Issue 3 - pp 222-230

 

3! - Treatment-Emergent Sexual Dysfunction Related to Antidepressants: A Meta-Analysis

Serretti, Alessandro; Chiesa, Alberto

Journal of Clinical Psychopharmacology: June 2009 - Volume 29 - Issue 3 - pp 259-266

 

5< - A Double-Blind, Placebo-Controlled Pilot Study of Galantamine to Improve Cognitive Dysfunction in Minimally Symptomatic Bipolar Disorder

Ghaemi, S. Nassir; Gilmer, William S; Dunn, Robert T; Hanlon, Robert E; Kemp, David E; Bauer, Amber D; Chriki, Lyvia; Filkowski, Megan M; Harvey, Philip D

Journal of Clinical Psychopharmacology: June 2009 - Volume 29 - Issue 3 - pp 291-295

 

3 - Thyroid hormones affect recovery from depression during antidepressant treatment

Chi-Un Pae, Laura Mandelli, Changsu Han, Byung-Joo Ham, Prakash S. Masand, Ashwin A. Patkar, David C. Steffens, Diana De Ronchi, and Alessandro Serretti

Psychiatry and Clinical Neurosciences. Volume 63 Issue 3, Pages 305 - 313

 

3! - Relationship between depressive mood and chronotype in healthy subjects

Maria Paz Hidalgo, Wolnei Caumo, Michele Posser, Sônia Beatriz Coccaro, Ana Luiza Camozzato, and Márcia Lorena Fagundes Chaves

Psychiatry and Clinical Neurosciences. Volume 63 Issue 3, Pages 283 - 290

 

3! - Antidepressant drugs with differing pharmacological actions decrease activity of locus coeruleus neurons

Charles H. K. West, James C. Ritchie, Katherine A. Boss-Williams and Jay M. Weiss

The International Journal of Neuropsychopharmacology (2009), 12:627-641

 

5< - Partial clinical response to 2 weeks of 2 Hz repetitive transcranial magnetic stimulation to the right parietal cortex in depression

Dennis J. L. G. Schutter, D. Martin Laman, Jack van Honk, Anton C. Vergouwen and G. Frank Koerselman

The International Journal of Neuropsychopharmacology (2009), 12:643-650

 

3 - Noradrenaline reuptake inhibitors limit neuroinflammation in rat cortex following a systemic inflammatory challenge: implications for depression and neurodegeneration

Joan B. O'Sullivan, Karen M. Ryan, Niamh M. Curtin, Andrew Harkin and Thomas J. Connor

The International Journal of Neuropsychopharmacology (2009), 12:687-699

 

3! - Generalized Anxiety Disorder, Major Depressive Disorder, and Their Comorbidity as Predictors of All-Cause and Cardiovascular Mortality: The Vietnam Experience Study

Anna C. Phillips, G. David Batty, Catharine R. Gale, Ian J. Deary, David Osborn, Kate MacIntyre, and Douglas Carroll

Psychosomatic Medicine 71:395-403 (2009)

3! - Depression and C-Reactive Protein: Population-Based Health 2000 Study

Marko Elovainio, Anna-Mari Aalto, Mika Kivimäki, Sami Pirkola, Jouko Sundvall, Jouko Lönnqvist, and Antti Reunanen

Psychosomatic Medicine 71:423-430 (2009)

3! - Peptic Ulcer and Mental Disorders Among Adults in the Community: The Role of Nicotine and Alcohol Use Disorders

Renee D. Goodwin, Katherine M. Keyes, Murray B. Stein, and Nicholas J. Talley

Psychosomatic Medicine 71:463-468 (2009)

3 - A Genomewide Association Study of Response to Lithium for Prevention of Recurrence in Bipolar Disorder

Roy H. Perlis, Jordan W. Smoller, Manuel A.R. Ferreira, Andrew McQuillin, Nick Bass, Jacob Lawrence, Gary S. Sachs, Vishwajit Nimgaonkar, Edward M. Scolnick, Hugh Gurling, Pamela Sklar, and Shaun Purcell

Am J Psychiatry Published May 15, 2009

3! - Symptoms associated with the DSM IV diagnosis of depression in pregnancy and post partum

Original Contribution

Symptoms associated with the DSM IV diagnosis of depression in pregnancy and post partum

Martin Kammerer, Maureen N. Marks, Claudia Pinard, Alyx Taylor, Brida von Castelberg, Hansjörg Künzli and Vivette Glover

Archives of Women's Mental Health. Volume 12, Number 3 / June, 2009: 135-141

 

3! - Mother’s stress, mood and emotional involvement with the infant: 3 months before and 3 months after childbirth

Original Contribution

Mother’s stress, mood and emotional involvement with the infant: 3 months before and 3 months after childbirth

Barbara Figueiredo and Raquel Costa

Archives of Women's Mental Health. Volume 12, Number 3 / June, 2009: 143-153

 

GRATIS 3! - Use of antidepressants and the risk of Parkinson’s disease: a prospective study

A Alonso, L A García Rodríguez, G Logroscino and M A Hernán

Journal of Neurology, Neurosurgery, and Psychiatry 2009;80:671-674

 

GRATIS 3 - Obsessive-compulsive disorder and related disorders: a comprehensive survey

Michele Fornaro, Filippo Gabrielli, Claudio Albano, Stefania Fornaro, Salvatore Rizzato, Chiara Mattei, Paola Solano, Valentina Vinciguerra and Pantaleo Fornaro

Annals of General Psychiatry 2009, 8:13

 

3 - Clinical Benefits and Cost Effectiveness of Vagus Nerve Stimulation in a Long-term Treatment of Patients with Major Depression

W. Sperling, U. Reulbach, J. Kornhuber

Pharmacopsychiatry 2009; 42: 85-88

3! - Placental Transfer of SSRI and SNRI Antidepressants and Effects on the Neonate

J. Rampono, K. Simmer, K. F. Ilett, L. P. Hackett, D. A. Doherty, R. Elliot, C. H. Kok, A. Coenen, T. Forman

Pharmacopsychiatry 2009; 42: 95-100

3 - Desipramine prevents stress-induced changes in depressive-like behavior and hippocampal markers of neuroprotection

Bravo, Javier A.; Díaz-Veliz, Gabriela; Mora, Sergio; Ulloa, José L.; Berthoud, Viviana M.; Morales, Paola; Arancibia, Sandor; Fiedler, Jenny Lucy

Behavioural Pharmacology: May 2009 - Volume 20 - Issue 3 - pp 273-285

 

GRATIS 3! - Diabetes mellitus and co-morbid depression: treatment with milnacipran results in significant improvement of both diseases (results from the Austrian MDDM study group)

Heidemarie Abrahamian, Peter Hofmann, Rudolf Prager, Hermann Toplak

Neuropsychiatric Disease and Treatment. May 2009

 

GRATIS 3 - Treatment and prevention of mania in bipolar I disorder: focus on aripiprazole

David J Muzina

Neuropsychiatric Disease and Treatment. May 2009

 

3 - Utility of Atypical Antipsychotics in the Treatment of Resistant Unipolar Depression

DeBattista, Charles; Hawkins, Jessica

CNS Drugs. 23(5):369-377, May 19, 2009

3! - Lithium: Updated Human Knowledge Using an Evidence-Based Approach: Part III: Clinical Safety

Grandjean, Etienne Marc; Aubry, Jean-Michel

CNS Drugs. 23(5):397-418, May 19, 2009

3! - Mirtazapine: A Review of its Use in Major Depression and Other Psychiatric Disorders

Croom, Katherine F.; Perry, Caroline M.; Plosker, Greg L

CNS Drugs. 23(5):427-452, May 19, 2009

3 - Deficit in BDNF does not increase vulnerability to stress but dampens antidepressant-like effects in the unpredictable chronic mild stress




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Yadira Ibarguen-Vargas, Alexandre Surget, Patrick Vourc’h, Samuel Leman, Christian R. Andres, Alain M. Gardier and Catherine Belzung

Behavioural Brain Research. Volume 202, Issue 2, 14 September 2009, Pages 245-251

 

3! - Effects of lorazepam on brain activity pattern during an anxiety symptom provocation challenge

T Schunck, A Mathis, G Erb, I J Namer, A Demazières, and R Luthringer

Journal of Psychopharmacology First published on May 21, 2009

3! - Benzodiazepine Use and Driving: A Meta-Analysis

Mark J. Rapoport, Krista L. Lanctôt, David L. Streiner, Michel Bédard, Evelyn Vingilis, Brian Murray, Ayal Schaffer, Kenneth I. Shulman, and Nathan Herrmann

J Clin Psychiatry 2009;70(5):663-673

 

5 - A Pooled Analysis of Suicidality in Double-Blind, Placebo-Controlled Studies of Sertraline in Adults

Douglas G. Vanderburg, Evan Batzar, Ilan Fogel, and Charlotte M. E. Kremer

J Clin Psychiatry 2009;70(5):674-683

 

3! - A Longitudinal Study of the Effects of Lithium Treatment on Prefrontal and Subgenual Prefrontal Gray Matter Volume in Treatment-Responsive Bipolar Disorder Patients

Gregory J. Moore, Bernadette M. Cortese, Debra A. Glitz, Caroline Zajac-Benitez, Jorge A. Quiroz, Thomas W. Uhde, Wayne C. Drevets, and Husseini K. Manji

J Clin Psychiatry 2009;70(5):699-705

 

5! - Duloxetine in the Prevention of Depressive Recurrences: A Randomized, Double-Blind, Placebo-Controlled Trial

David G. S. Perahia, Giuseppe Maina, Michael E. Thase, Melissa E. Spann, Fujun Wang, Daniel J. Walker, and Michael J. Detke

J Clin Psychiatry 2009;70(5):706-716

 

3! - What happens to patients with treatment-resistant depression? A systematic review of medium to long term outcome studies




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Abebaw Fekadu, Sarah C. Wooderson, Kalypso Markopoulo, Catherine Donaldson, Andrew Papadopoulos and Anthony J. Cleare

Journal of Affective Disorders. Volume 116, Issues 1-2, July 2009, Pages 4-11

 

3 - Age-at-onset in bipolar-I disorder: Mixture analysis of 1369 cases identifies three distinct clinical sub-groups




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Marian L. Hamshere, Katherine Gordon-Smith, Liz Forty, Lisa Jones, Sian Caesar, Christine Fraser, Sally Hyde, John Tredget, George Kirov, Ian Jones, Nick Craddock and Daniel J. Smith

Journal of Affective Disorders. Volume 116, Issues 1-2, July 2009, Pages 23-29

 

4 - Maintenance of response following stabilization of mixed index episodes with olanzapine monotherapy in a randomized, double-blind, placebo-controlled study of bipolar 1 disorder




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Mauricio Tohen, Virginia K. Sutton, Joseph R. Calabrese, Gary S. Sachs and Charles L. Bowden

Journal of Affective Disorders. Volume 116, Issues 1-2, July 2009, Pages 43-50

 

3 - Medical and substance use comorbidity in bipolar disorder




References and further reading may be available for this article. To view references and further reading you must purchase this article.

David E. Kemp, Keming Gao, Stephen J. Ganocy, Emily Caldes, Kathryn Feldman, Philip K. Chan, Carla Conroy, Sarah Bilali, Robert L. Findling and Joseph R. Calabrese

Journal of Affective Disorders. Volume 116, Issues 1-2, July 2009, Pages 64-69

 

3! - HPA axis hyperactivity and cardiovascular mortality in mood disorder inpatients




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Jussi Jokinen and Peter Nordström

Journal of Affective Disorders. Volume 116, Issues 1-2, July 2009, Pages 88-92

 

3! - Randomized comparison of ultra-brief bifrontal and unilateral electroconvulsive therapy for major depression: Clinical efficacy




References and further reading may be available for this article. To view references and further reading you must purchase this article.

P. Sienaert, K. Vansteelandt, K. Demyttenaere and J. Peuskens

Journal of Affective Disorders. Volume 116, Issues 1-2, July 2009, Pages 106-112

 

2! - Maternal Use of Venlafaxine Near Term: Correlation Between Neonatal Effects and Plasma Concentrations

Boucher, Nina; Koren, Gideon; Beaulac-Baillargeon, Louise

Therapeutic Drug Monitoring. 31(3):404-409, June 2009

3! - Randomized Antidepressant Therapy and Pain Self-management in Primary Care Patients With Depression and Musculoskeletal Pain. Randomized Controlled Trial

Kurt Kroenke, Matthew J. Bair, Teresa M. Damush, Jingwei Wu, Shawn Hoke, Jason Sutherland, Wanzhu Tu

JAMA. 2009;301(20):2099-2110

 

3 - Current investigational drugs for major depression

Shrinivas K Kulkarni & Ashish Dhir

Expert Opinion on Investigational Drugs. June 2009, Vol. 18, No. 6, Pages 767-788

 

GRATIS 4< - A comparison of low-dose risperidone to paroxetine in the treatment of panic attacks: a randomized single-blind study

James M Prosser, Samantha Yard, Annie Steele, Lisa J Cohen and Igor I Galynker

BMC Psychiatry 2009, 9:25

 

4! - How long should a trial of escitalopram treatment be in patients with major depressive disorder, generalised anxiety disorder or social anxiety disorder? An exploration of the randomised controlled trial database

David S. Baldwin, Dan J. Stein, Ornah T. Dolberg, Borwin Bandelow

Human Psychopharmacology: Clinical and Experimental. Volume 24 Issue 4, Pages 269 - 275

 

3! - Oxidative stress parameters after combined fluoxetine and acetylsalicylic acid therapy in depressive patients

Piotr Galecki, Janusz Szemraj, Malgorzata Bienkiewicz, Krzysztof Zboralski, Elzbieta Galecka

Human Psychopharmacology: Clinical and Experimental. Volume 24 Issue 4, Pages 277 - 286

 

3 - MAOA gene polymorphisms and response to mirtazapine in major depression

Dong-Sheng Tzeng, Chia-Chang Chien, For-Wey Lung, Chun- Yuh Yang

Human Psychopharmacology: Clinical and Experimental. Volume 24 Issue 4, Pages 293 - 300

 

3 - The SNRI venlafaxine improves emotional unawareness in patients with post-stroke depression

Luca Cravello, Carlo Caltagirone, Gianfranco Spalletta

Human Psychopharmacology: Clinical and Experimental. Volume 24 Issue 4, Pages 331 - 336

 

3! - Prefrontal asymmetry in depression? The long-term effect of unilateral brain lesions




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Michael Koenigs and Jordan Grafman

Neuroscience Letters. Volume 459, Issue 2, 7 August 2009, Pages 88-90

 

3! - Neurogenesis-Dependent and -Independent Effects of Fluoxetine in an Animal Model of Anxiety/Depression




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Denis J. David, Benjamin Adam Samuels, Quentin Rainer, Jing-Wen Wang, Douglas Marsteller, Indira Mendez, Michael Drew, Douglas A. Craig, Bruno P. Guiard, Jean-Philippe Guilloux, Roman P. Artymyshyn, Alain M. Gardier, Christophe Gerald, Irina A. Antonijevic, E. David Leonardo and René Hen

Neuron. Volume 62, Issue 4, 28 May 2009, Pages 479-493

 

GRATIS 3 - Towards achieving remission in the treatment of depresión

Julien Mendlewicz

Dialogues Clin Neurosci. 2008;10:371-375

 

GRATIS 3 - Treatment strategies to improve and sustain remission in major depressive disorder

Madhukar H. Trivedi,  Ella J. Daly

Dialogues Clin Neurosci. 2008;10:377-384

 

GRATIS 3! - Cellular and molecular mechanisms in the long-term action of antidepressants

Giorgio Racagni, Maurizio Popoli

Dialogues Clin Neurosci. 2008;10:385-400

 

GRATIS 3! - Pharmacogenomic strategy for individualizing antidepressant therapy

Keh-Ming Lin,  Roy H. Perlis,  Yu-Jui Yvonne Wan

Dialogues Clin Neurosci. 2008;10:401-408

 

GRATIS 3 - Toward achieving optimal response: understanding and managing antidepressant side effects

Karen Kelly, Michael Posternak,  Jonathan E. Alpert

Dialogues Clin Neurosci. 2008;10:409-418

 

GRATIS 3 - Incomplete response in late-life depression: getting to remission

Eric J. Lenze,  Meera Sheffrin,  Henry C. Driscoll,  Benoit H. Mulsant,  Bruce G. Pollock,  Mary Amanda Dew, Frank Lotrich,  Bernie Devlin,  Robert Bies,  Charles F. Reynolds III

Dialogues Clin Neurosci. 2008;10:419-430

 

GRATIS 3 - Partial remission, residual symptoms, and relapse in depresión

E. S. Paykel

Dialogues Clin Neurosci. 2008;10:431-437

 

GRATIS 3 - Predictors, moderators, and mediators (correlates) of treatment outcome in major depressive disorder

George I. Papakostas,  Maurizio Fava

Dialogues Clin Neurosci. 2008;10:439-451

 

GRATIS 3 - Incomplete remission in depression: role of psychiatric and somatic comorbidity

Christian Otte

Dialogues Clin Neurosci. 2008;10:453-460

 

GRATIS 3 - Sleep disturbances and depression: risk relationships for subsequent depressionand therapeutic implications

Peter L. Franzen,  Daniel J. Buysse

Dialogues Clin Neurosci. 2008;10:473-481

 

GRATIS 3 - Neurochemical brain imaging of treatment response in geriatric depresión

Smith GS

Dialogues Clin Neurosci. 2008;10:482-486

 

GRATIS 3! - Obsessive–Compulsive Spectrum Disorders: A Review of the Evidence-Based Treatments

Arun V Ravindran, Tricia L da Silva, Lakshmi N Ravindran, Margaret A Richter, Neil A Rector

Can J Psychiatry. 2009;54(5):331–343

 

GRATIS 3 (previo registro) - Selective Serotonin Reuptake Inhibitor Use During Pregnancy and Possible Neonatal Complications

Jillan Cantor Sackett, Ronald A. Weller, and Elizabeth B. Weller

Current Psychiatry Reports 2009, 11: (3) 253-257

 

GRATIS 3! - Antidepressants: Brand Name or Generic?

James W. Jefferson

Psychiatric Times. 2009; Vol. 26 No. 5

 

GRATIS 3 - Antipsychotic Combination Strategies in Bipolar Disorder. Strategies to Maximize Treatment Adherence

David J. Muzina, and Martha Sajatovic

Psychiatric Times. April 14, 2009

.

Regresar a RESÚMENES MAYO 2009

.

© 1999-2009 Jorge M Tamayo, MD, BMSS

Creada en Enero 1999

Declaración: El contenido de esta página web está basado en las revisiones de la literatura realizadas por el autor y las colaboraciones enviadas por los lectores. Este sitio de Internet está dirijido únicamente a profesionales de la salud en Iberoamérica. Si usted es residente de Estados Unidos de América o Europa, debe tener en cuenta que los contenidos no han sido escogidos con base en información aprobada por la FDA o la EMEA.